Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of imaging markers of cartilage degradation with DROGLICAN in knee osteoarthritis
2015-005681-37Phase 4Completed
- Sponsor
- Bioiberica
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Droglican in knee osteoarthritis (OA), sponsored by Bioiberica. Primary endpoint: dGEMRIC index. Started Feb 2016; status: completed.
02
Drugs
Droglican
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2015-005681-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005681-37.